MLH1 Differential allelic expression in mutation carriers and controls

Area of Science:

• Genetics
• Molecular Biology
• Cancer Genomics

Background:

• Germline defects in the MLH1 gene are a primary cause of Lynch syndrome.
• Many MLH1 mutations result in premature termination codons, triggering nonsense-mediated decay (NMD).
• Allelic expression differences (AEI) offer a potential diagnostic marker.

Purpose of the Study:

• To evaluate the utility of AEI detection in whole blood RNA for identifying MLH1 mutations.
• To investigate the impact of mutation location on AEI.
• To identify sequence variations influencing MLH1 expression in healthy individuals.

Main Methods:

• RNA extraction from whole blood samples.
• Mass spectrometry-based detection of allelic expression imbalance (AEI).
• Maximum likelihood framework analysis to identify expression-associated single nucleotide polymorphisms (SNPs).

Main Results:

• AEI was readily detected in patients with MLH1 mutations predicted to cause NMD.
• Mutations located nearer the 5' end of the MLH1 gene exhibited smaller expression imbalances.
• Two SNPs (rs1799977 and rs1800734) were identified as independently influencing MLH1 expression, though their effect was minor compared to pathological variants.

Conclusions:

• AEI in whole blood RNA is a viable, cost-effective method for detecting MLH1 mutations associated with Lynch syndrome.
• Understanding cis-acting sequence variations is crucial for interpreting AEI data.
• This approach facilitates faster and more accessible genetic screening for Lynch syndrome.